Clinical Trials Directory

Trials / Unknown

UnknownNCT03178305

Do Cardiac Health: Advanced New Generation Ecosystem - Phase 2

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
250 (actual)
Sponsor
Elisabeth-TweeSteden Ziekenhuis · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The Do CHANGE service is designed for cardiac patients who could benefit from lifestyle change and a better disease management. The study aims to support patients with behavior change by providing them with devices and behavioral intervention in order to facilitate long-term behavior change.

Detailed description

The focus of the Do CHANGE project is on empowering individuals with high blood pressure, ischemic heart disease or heart failure with tools and services to optimally monitor and manage their real-time health condition and disease. The innovative approach of the Do CHANGE project also involves the patients' surrounding health ecosystem in the process. The traditional difficulties of therapy adherence in a physician-centred care system are radically abandoned and replaced by a patient-centred approach. The approach advocated by Do CHANGE project focuses on the needs of the patient by not only providing them with innovative tools that assess the patient's real-time health condition, but also offer a variety of behavioural alternatives. The main hypothesis of the Do CHANGE project is that patients' disease self-management and lifestyle will improve as compared to self-management of patients who receive the care as usual.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDo CHANGEBesides the behavior change programme (Do Something Different) 1. All patients will receive: Fitbit, Beddit, Care-portal, Do CHANGE app (including dietary habits picture taking), CookiT (smart spatula that monitors cooking behavior) 2. patients with heart failure will, in addition to the above mentioned, be offered a weight scale, blood pressure monitor, and FluiT (smart cup to measure fluid intake). 3. Patients with hypertension will also be offered a bloodpressure monitor. Data from these devices will be gathered and visible for patients (in patient portal) and for their health care provider (health care provider portal). In case of negative results the patient will be contacted by their health care provider (usually the cardiologist). Once every week the patients will be contacted to discuss their progress and will be given feedback about their dietary intake.

Timeline

Start date
2017-07-27
Primary completion
2018-07-31
Completion
2018-07-31
First posted
2017-06-06
Last updated
2018-07-26

Locations

2 sites across 2 countries: Spain, Taiwan

Source: ClinicalTrials.gov record NCT03178305. Inclusion in this directory is not an endorsement.